An electrical impulse is generated in the human heart to maintain proper pumping of blood from the heart to the body cells. This electrical impulse can be measured to detect if there is any disruption of blood flow inside the human body. Cardiology electrodes are conductive pads that are attached to the body to receive electrical signals from the heart. These electrodes pads are sticker-like and are usually placed on limbs and chest to monitor heart activity. ECG machine detects, analyzes, amplifies, and presents the signals generated by two or more electrodes into a readable format. The graphical representation of electrical signals generated by several electrodes is known as electrocardiogram (ECG) lead and the procedure of generating an electrocardiogram is known as electrocardiography. One of the most commonly used electrocardiograph for diagnosis of such cardiac events is the 12-lead ECG which comprises of 10 electrodes and provides sensitivity and feasibility. Rapid research in the field of cardiology has led to several opportunities for development of newer technologies for improvement of cardiology electrodes for diagnosis of cardiovascular conditions.
Market Dynamics
Increasing adoption of inorganic strategies by key players in market such as acquisitions is expected to drive market growth over the forecast period. For instance, In June 2018, Nissha Co., Ltd., a medical device company, announced the acquisition of Sequel Special Products, LLC, a company engaged in the contract manufacturing of medical devices, and its affiliated company RSS Design, LLC, which is engaged in the development and design of medical devices
Key features of the study:
- This report provides in-depth analysis of the global cardiology electrodes market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cardiology electrodes market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Amgen Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., Pfizer Inc., Sanofi, Eli Lilly and Company, AbbVie Inc., Novo Nordisk A/S, Bristol-Myers Squibb Company, NanoString, QIAGEN, Affimed GmbH, GSK plc., Merck KgaA, and Teva Pharmaceutical Industries Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global cardiology electrodes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiology electrodes market
Detailed Segmentation:
- Global Cardiology Electrodes Market, By Product Type:
- Resting ECG Electrodes
- Short-term Monitoring ECG Electrodes
- Long-term Monitoring ECG Electrodes
- Stress Test ECG Electrodes
- Neonatal ECG Electrodes
- Pediatric ECG Electrodes
- Global Cardiology Electrodes Market, By Order Type:
- Sticky Gel Cardiology Electrodes
- Wet Gel Cardiology Electrodes
- Dry Cardiology Electrodes
- Solid Gel Cardiology Electrodes
- Global Cardiology Electrodes Market, By Usability:
- Disposable Medical Electrodes
- Reusable Medical Electrodes
- Global Cardiology Electrodes Market, By End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
- Global Cardiology Electrodes Market, By Region:
- North America
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Region/Country
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Leonhard Lang
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Nissha Medical Technologies
- Conmed Corporation
- Koninklijke Philips N.V.
- GE Healthcare (General Electric Company)
- Medtronic plc
- BPL Medical Technologies
- FARUM sp. z o.o.
- COM.
- Promed Technology Co., Ltd.
- 3M
- VectraCor
- Medico Electrodes International Ltd.
- Ambu A/S.
- Cardinal Health
“*” marked represents similar segmentation in other categories in the respective section.
